Champions Oncology (CSBR) Equity Ratio (2011 - 2026)

Champions Oncology's Equity Ratio history runs 16 years deep, the most recent figure standing at 0.15 for Q1 2026.

• In Q1 2026, Equity Ratio fell 15.68% year-over-year to 0.15; the TTM figure through Jan 2026 stood at 0.15 (down 15.68% YoY), while the FY2025 annual figure was 0.12, up 260.14% from the prior year.
• Equity Ratio was 0.15 for Q1 2026 at Champions Oncology, up from 0.14 in the prior quarter.
• In the past five years, Equity Ratio ranged from a high of 0.28 in Q1 2022 to a low of 0.08 in Q1 2024.
• Historically, Equity Ratio has averaged 0.12 across 5 years, with a median of 0.14 in 2023.
• The sharpest annual moves came in 2024 and 2025: Equity Ratio plunged 153.9% in 2024, then surged 969.84% in 2025.
• A 5-year view of Equity Ratio shows it stood at 0.25 in 2022, then tumbled by 98.7% to 0.0 in 2023, then jumped by 720.86% to 0.03 in 2024, then surged by 419.91% to 0.14 in 2025, then gained by 7.33% to 0.15 in 2026.
• The last three Equity Ratio figures came in at 0.15 (Q1 2026), 0.14 (Q4 2025), and 0.12 (Q3 2025), per Business Quant data.